These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 16176072
1. Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. Lee HJ, Ghelardoni S, Chang L, Bosetti F, Rapoport SI, Bazinet RP. Neurochem Res; 2005 May; 30(5):677-83. PubMed ID: 16176072 [Abstract] [Full Text] [Related]
2. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ. Biol Psychiatry; 2006 Mar 01; 59(5):401-7. PubMed ID: 16182257 [Abstract] [Full Text] [Related]
3. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ. Psychopharmacology (Berl); 2005 Oct 01; 182(1):180-5. PubMed ID: 15986187 [Abstract] [Full Text] [Related]
4. Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder. Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP. Psychopharmacology (Berl); 2007 Sep 01; 193(4):467-74. PubMed ID: 17487474 [Abstract] [Full Text] [Related]
5. Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism. Ghelardoni S, Bazinet RP, Rapoport SI, Bosetti F. Psychopharmacology (Berl); 2005 Jul 01; 180(3):523-9. PubMed ID: 15719218 [Abstract] [Full Text] [Related]
6. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. Chang MC, Contreras MA, Rosenberger TA, Rintala JJ, Bell JM, Rapoport SI. J Neurochem; 2001 May 01; 77(3):796-803. PubMed ID: 11331408 [Abstract] [Full Text] [Related]
7. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder. Shimshoni JA, Basselin M, Li LO, Coleman RA, Rapoport SI, Modi HR. Biochim Biophys Acta; 2011 Mar 01; 1811(3):163-9. PubMed ID: 21184843 [Abstract] [Full Text] [Related]
8. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Chang MC, Bell JM, Purdon AD, Chikhale EG, Grange E. Neurochem Res; 1999 Mar 01; 24(3):399-406. PubMed ID: 10215514 [Abstract] [Full Text] [Related]
9. Arachidonic acid and the brain. Rapoport SI. J Nutr; 2008 Dec 01; 138(12):2515-20. PubMed ID: 19022981 [Abstract] [Full Text] [Related]
10. Modification of milk formula to enhance accretion of long-chain n-6 and n-3 polyunsaturated fatty acids in artificially reared infant rats. Yeh YY, Yeh SM, Lien EL. Lipids; 1998 May 01; 33(5):513-20. PubMed ID: 9625599 [Abstract] [Full Text] [Related]
11. Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats. Contreras MA, Chang MC, Rosenberger TA, Greiner RS, Myers CS, Salem N, Rapoport SI. J Neurochem; 2001 Dec 01; 79(5):1090-9. PubMed ID: 11739623 [Abstract] [Full Text] [Related]
12. Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP. J Lipid Res; 2008 Jan 01; 49(1):162-8. PubMed ID: 17957090 [Abstract] [Full Text] [Related]
13. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade. Rapoport SI. ACS Chem Neurosci; 2014 Jun 18; 5(6):459-67. PubMed ID: 24786695 [Abstract] [Full Text] [Related]
14. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Rapoport SI, Bosetti F. Arch Gen Psychiatry; 2002 Jul 18; 59(7):592-6. PubMed ID: 12090811 [Abstract] [Full Text] [Related]
15. Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. Rosenberger TA, Villacreses NE, Weis MT, Rapoport SI. Neurochem Int; 2010 Feb 18; 56(3):501-7. PubMed ID: 20026368 [Abstract] [Full Text] [Related]
16. Liver conversion of docosahexaenoic and arachidonic acids from their 18-carbon precursors in rats on a DHA-free but α-LNA-containing n-3 PUFA adequate diet. Gao F, Kim HW, Igarashi M, Kiesewetter D, Chang L, Ma K, Rapoport SI. Biochim Biophys Acta; 2011 Feb 18; 1811(7-8):484-9. PubMed ID: 21651989 [Abstract] [Full Text] [Related]
17. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain. Cheon Y, Park JY, Modi HR, Kim HW, Lee HJ, Chang L, Rao JS, Rapoport SI. J Neurochem; 2011 Oct 18; 119(2):364-76. PubMed ID: 21812779 [Abstract] [Full Text] [Related]
18. Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder. Reese EA, Cheon Y, Ramadan E, Kim HW, Chang L, Rao JS, Rapoport SI, Taha AY. Prostaglandins Leukot Essent Fatty Acids; 2012 Oct 18; 87(2-3):71-7. PubMed ID: 22841517 [Abstract] [Full Text] [Related]
19. Chronic dietary n-6 PUFA deprivation leads to conservation of arachidonic acid and more rapid loss of DHA in rat brain phospholipids. Lin LE, Chen CT, Hildebrand KD, Liu Z, Hopperton KE, Bazinet RP. J Lipid Res; 2015 Feb 18; 56(2):390-402. PubMed ID: 25477531 [Abstract] [Full Text] [Related]
20. Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. Lee HJ, Rao JS, Ertley RN, Chang L, Rapoport SI, Bazinet RP. Psychopharmacology (Berl); 2007 Jan 18; 190(1):103-15. PubMed ID: 17093977 [Abstract] [Full Text] [Related] Page: [Next] [New Search]